192 related articles for article (PubMed ID: 15019868)
1. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.
Quinn MJ; Bhatt DL; Zidar F; Vivekananthan D; Chew DP; Ellis SG; Plow E; Topol EJ
Am J Cardiol; 2004 Mar; 93(6):679-84. PubMed ID: 15019868
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Xiao Z; Théroux P
J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
7. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
9. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
Antonino MJ; Mahla E; Bliden KP; Tantry US; Gurbel PA
Am J Cardiol; 2009 Jun; 103(11):1546-50. PubMed ID: 19463513
[TBL] [Abstract][Full Text] [Related]
11. Platelet function in clopidogrel-treated patients with acute coronary syndrome.
Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):335-9. PubMed ID: 17473574
[TBL] [Abstract][Full Text] [Related]
12. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
[TBL] [Abstract][Full Text] [Related]
13. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
Gurbel PA; Cummings CC; Bell CR; Alford AB; Meister AF; Serebruany VL;
Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840
[TBL] [Abstract][Full Text] [Related]
14. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
[TBL] [Abstract][Full Text] [Related]
16. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
Lev EI; Arikan ME; Vaduganathan M; Alviar CL; Tellez A; Mathuria N; Builes A; Granada JF; del Conde I; Kleiman NS
Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
[TBL] [Abstract][Full Text] [Related]
19. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
[TBL] [Abstract][Full Text] [Related]
20. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
Smith SM; Judge HM; Peters G; Storey RF
Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
